p-Chlorophenacyl bromide → HCID 12837734, compound
Reaction equation
[CH2:1]1[CH:6]2[C:7]3[N:8]([CH:16]=[CH:17][CH:18]=3)[CH2:9][C:10]3[CH:15]=[CH:14][CH:13]=[CH:12][C:11]=3[N:5]2[CH2:4][CH2:3][NH:2]1.Br[CH2:20][C:21]([C:23]1[CH:28]=[CH:27][C:26]([Cl:29])=[CH:25][CH:24]=1)=[O:22]>CN(C)C=O.C(N(CC)CC)C.C(OCC)C>[Cl:29][C:26]1[CH:27]=[CH:28][C:23]([C:21]([CH2:20][N:2]2[CH2:3][CH2:4][N:5]3[C:11]4[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=4[CH2:9][N:8]4[CH:16]=[CH:17][CH:18]=[C:7]4[CH:6]3[CH2:1]2)=[O:22])=[CH:24][CH:25]=1Participants
6
Reactant 2
Product 1
Reagents, catalysts & solvents 3
Procedure
To the solution of 500 mg of 1,3,4,14b-tetrahydro-2H,10H-pyrazino[1,2-a]pyrrolo[2,1-c][1,4]benzodiazepine in 7.5 ml of dimethylformamide and 350 mg of triethylamine, 470 mg of α-bromo-p-chloroacetophenone are added and the mixture is stirred at room temperature for 2 hours. It is diluted with 60 ml of diethyl ether, washed with water, dried and evaporated. The residue is taken up in 15 ml of chloroform and the solution again evaporated, to yield the 2-(p-chlorobenzoylmethyl)-1,3,4,14b-tetrahydro-10H-pyrazino[1,2-a]pyrrolo[2,1-c][1,4]benzodiazepine melting at 71°-74°.
Workup
- washwashed with water
- customdried
- customevaporated
- customthe solution again evaporated
Sources & evidence
- ORD record
- ord-5263085dac424a4eaf21d583e073b24b
- Source dataset
- uspto-grants-1982_02
- Patent number
- US04316900
Reaction notes
Loading…